One in three South Korean COVID-19 patients improve with remdesivir - Reuters 14-Jul-2020

on July 14, 2020

One in three South Korean COVID-19 patients improve with remdesivir - Reuters

One in three South Korean patients seriously ill with COVID-19 showed an improvement in their condition after being given Gilead Sciences Inc's antiviral remdesivir, health authorities said.